AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Pharming Group NV partners with Transmedic Pte Ltd to bring RUCONEST to HAE patients in parts of South East Asia.
(From M2 Equity Bites)
M2 EQUITYBITES-February 15, 2012-Pharming Group NV partners with Transmedic Pte Ltd to bring RUCONEST to HAE patients in parts of South- East Asia (C)1994-2012 M2 COMMUNICATIONS http://www.m2.com
Biotech company Pharming Group NV (NYSE Euronext:PHARM) revealed on Tuesday the execution of an agreement for the commercialisation of RUCONEST (recombinant human C1 inhibitor) for the treatment of acute attacks of Hereditary Angioedema (HAE) in parts of South- East Asia.
The …
-
- Pharming and Transmedic sign distribution agreement for RUCONEST in southeast...
-
News wire article from: Europe Intelligence Wire
February 15, 2012
700+ words
-
- Eriks Group buys engineering parts supplier Wyko for 139 mln stg.
-
News wire article from: Europe Intelligence Wire
October 19, 2006
700+ words
-
- Pharming JanSep net loss shrinks to EUR13.3m.(Financial report)
-
News wire article from: Europe Intelligence Wire
November 17, 2011
700+ words
